These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13993194)

  • 21. [ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS].
    LUCCHESI M; BANCALE A; ROSSI P
    Ann Ist Carlo Forlanini; 1963; 23():235-52. PubMed ID: 14122048
    [No Abstract]   [Full Text] [Related]  

  • 22. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 23. PULMONARY TUBERCULOSIS.
    CHAVES AD
    Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
    [No Abstract]   [Full Text] [Related]  

  • 24. ETHIONAMIDE-CYCLOSERINE THERAPY FOR AMBULATORY PATIENTS WITH PULMONARY TUBERCULOSIS UNRESPONSIVE TO STANDARD DRUGS.
    CHAVES AD; ABELES H; ROBINS AB
    Am Rev Respir Dis; 1963 Aug; 88():254-6. PubMed ID: 14045232
    [No Abstract]   [Full Text] [Related]  

  • 25. A CONTROLLED CLINICAL TRIAL OF ETHIONAMIDE, CYCLOSERINE AND PYRAZINAMIDE IN PREVIOUSLY TREATED PATIENTS WITH PULMONARY TUBERCULOSIS.
    BOESZOERMENYI M; FAUSZT I; BARAT I; SCHWEIGER O
    Tubercle; 1965 Jun; 46():143-50. PubMed ID: 14327962
    [No Abstract]   [Full Text] [Related]  

  • 26. A controlled comparison of cycloserine plus ethionamide with cycloserine plus thiacetazone in patients with active pulmonary tuberculosis despite prolonged previous chemotherapy.
    ANGEL JH; BHATIA AL; DEVADATTA S; FOX W; JANARDHANAM B; RADHAKRISHNA S; RAMAKRISHNAN CV; SELKON JB; STOTT H; VELU S
    Tubercle; 1963 Jun; 44():215-24. PubMed ID: 14013125
    [No Abstract]   [Full Text] [Related]  

  • 27. [ASSOCIATION OF ETHIONAMIDE-CYCLOSERINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO THE 1ST LINE DRUGS].
    PEREZ JA; FARIAS CE
    Rev Esp Tuberc; 1964 May; 33():197-208. PubMed ID: 14169311
    [No Abstract]   [Full Text] [Related]  

  • 28. DRUG THERAPY FOR TUBERCULOUS PATIENTS OUTSIDE THE HOSPITAL.
    CHAVES AD
    Med Ann Dist Columbia; 1963 Sep; 32():361-8. PubMed ID: 14045044
    [No Abstract]   [Full Text] [Related]  

  • 29. [ETHIONAMIDE-CYCLOSERINE COMBINATION IN THE TREATMENT OF PULMONARY TUBERCULOSIS CAUSED BY BACTERIA RESISTANT TO THE USUAL DRUGS].
    PEREZ JA; FARIAS CE
    Torax; 1963; 12():126-32. PubMed ID: 14158168
    [No Abstract]   [Full Text] [Related]  

  • 30. A PRELIMINARY REPORT ON A NEW ANTITUBERCULOUS DRUG 4-AMINO-2-HYDROXY-PHENYL-1, 3, 4,-OXADIAZOL-2-OL WS 127.
    SMITH AE; ASPEVIK E; EVENSTAD E; HAUKENES G
    Acta Tuberc Pneumol Scand; 1964; 45():231-55. PubMed ID: 14234467
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of chronic polyresistant pulmonary tuberculosis using ethionamide, pyrazinamide and cycloserine].
    Sighart H; Opl G
    Prax Pneumol; 1968 Nov; 22(11):692-8. PubMed ID: 5714048
    [No Abstract]   [Full Text] [Related]  

  • 32. [EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].
    TSUCHIMOCHI T
    Kekkaku; 1963 Jun; 38():264-9. PubMed ID: 14046673
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment of advanced isonizid- and streptomycin-resistant pulmonary tuberculosis with ethionamide, pyrazinamide, and isoniazid.
    PETTY TL; MITCHELL RS
    Am Rev Respir Dis; 1962 Oct; 86():503-12. PubMed ID: 13942996
    [No Abstract]   [Full Text] [Related]  

  • 34. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 35. ["2ND LINE" DRUG THERAPY IN CHRONIC TUBERCULOSIS DUE TO GERM RESISTANCE. (NEW METHODS OF DRUG ADMINISTRATION; NEW DRUGS)].
    HAMMERLI A; KRAMER EE; GALLINDO IS
    Hospital (Rio J); 1964 Feb; 65():365-88. PubMed ID: 14136756
    [No Abstract]   [Full Text] [Related]  

  • 36. [NEW DRUGS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    LESTON JM
    Sem Med; 1964 Apr; 124():855-60. PubMed ID: 14181019
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 38. [THE CLINICAL ASPECTS OF ATYPICAL PULMONARY MYCOBACTERIOSIS].
    ALMANSAPASTOR A
    Rev Esp Tuberc; 1964 Jan; 33():1-8. PubMed ID: 14132983
    [No Abstract]   [Full Text] [Related]  

  • 39. [CHEMO-ANTIBIOTIC THERAPY IN PULMONARY TUBERCULOSIS].
    RUSSO V
    Rass Int Clin Ter; 1963 Sep; 43():1009-13. PubMed ID: 14091636
    [No Abstract]   [Full Text] [Related]  

  • 40. [EVALUATION OF THERAPEUTIC RESULTS IN CHRONIC CAVITARY TUBERCULOSIS TREATED WITH ETHIONAMIDE, CYCLOSERINE AND PYRAZINAMIDE. (A JOINT STUDY ON RESULTS AND PROSPECTS)].
    FORTIC B; KOMAR M
    Tuberkuloza; 1964; 16():359-71. PubMed ID: 14306418
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.